Pharmacogenomic tests in Oncology - finding the right dose
A pharmacogenetics/genomics (PGx) anticancer drug testing program is being developed by Kurtz and his group at the Brazilian National Cancer Institute (INCA). Drug -gene pairs were selected for PGx testing based on the presence of clinically validated PGx associations and the availability of interna...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Thieme Revinter Publicações Ltda.
2021-10-01
|
| Cyfres: | Brazilian Journal of Oncology |
| Pynciau: | |
| Mynediad Ar-lein: | http://www.brazilianjournalofoncology.com.br/details/153/en-US/pharmacogenomic-tests-in-oncology---finding-the-right-dose |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|